Connor, Clark & Lunn Investment Management Ltd. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,077,523
+74.0%
492,304
+27.8%
0.01%
+83.3%
Q2 2023$1,194,163
+159.9%
385,214
+16.6%
0.01%
+200.0%
Q1 2023$459,391
-1.4%
330,497
+41.2%
0.00%
-33.3%
Q4 2022$465,893
+50.3%
234,117
+52.3%
0.00%
+50.0%
Q3 2022$310,000
+342.9%
153,690
+753.2%
0.00%
Q3 2020$70,000
-95.1%
18,014
-94.0%
0.00%
-100.0%
Q2 2020$1,424,000
+124.6%
299,067
+64.1%
0.01%
+66.7%
Q1 2020$634,000182,2910.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders